arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

PLUS THERAPEUTICS, INC.

PSTV
$3.87 0.00 (0.00%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
68 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

PLUS THERAPEUTICS, INC. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $26.7M
Dividend Yield —
Revenue Growth -70.4% ↘
Op. Margin None
ROIC -131.0% ↘
FCF / Share $-1.11 ↘
Trailing P/E —
Price / Book 5.2x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Jul 31, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$411.00K
↓ -70.4% —
Net Income Profit after all expenses
$-6.95M
↑ +60.1% —
Operating Margin Operating profit as % of sales
-420.0%
↓ -30.9% 0th
FCF / Share Free cash flow per share
$-1.11
↓ -4.2% —
Long-Term Debt Long-term obligations
$3.79M
↓ -7.8% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
0
Cash Quality ↑
62

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters